Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department (NCT06114602) | Clinical Trial Compass
UnknownNot Applicable
Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department
Argentina1,892 participantsStarted 2022-01-01
Plain-language summary
In this observational study, the investigators will analyze all patients who have scheduled appointments in the Urology Department from twelve months before the start date of the e-mail reminder dispatch (01/02/2023) to twelve months after (01/01/2022 to 31/12/2023). The investigators will divide them into two groups based on whether they have received the reminder or not. The investigators are going to compare the rate of no-show rates in both groups and then obtain the relative risk of the association between appointment reminders and no-show rates.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* We will include all patients over 18 years who have been assigned appointments or overappointments, scheduled or with note, in the Urology Department of HIBA between January 1, 2022 and December 31, 2023.
Exclusion Criteria:
* Teleconsultation appointments and face-to-face consultations made through spontaneous overappointments or spontaneous demand will be excluded. The latter two cases are not considered to be appointments assigned to the patient prior to the consultation, but are assigned at the same time the patient presents his or her request. The electronic information system has no way of knowing in advance that this patient is going to be seen and therefore has no way of sending a reminder.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.